Cotson-IM/IV 100mg/2ml Injection

Indications for Cotson 100 mg/2 ml include:

1. Primary or secondary adrenocortical insufficiency
2. Acute adrenocortical insufficiency
3. Shock unresponsive to conventional therapy
4. Congenital adrenal hyperplasia
5. Hypercalcemia associated with cancer
6. Nonsuppurative thyroiditis
7. Rheumatic Disorders
8. Dermatologic Diseases (Allergic States, Severe seborrheic dermatitis, Severe psoriasis, Pemphigus, Severe erythema multiforme)
9. Control of severe or incapacitating allergic conditions (Bronchial asthma, Contact dermatitis, Atopic dermatitis, Serum sickness, Seasonal or perennial allergic rhinitis, Drug hypersensitivity reactions, Urticarial transfusion reactions, Acute noninfectious laryngeal edema)
10. Ophthalmic Diseases (Herpes zoster ophthalmicus, Iritis, iridocyclitis, Chorioretinitis, Diffuse posterior uveitis and choroiditis, Optic neuritis)
11. Gastrointestinal Diseases
12. Fulminating or disseminated pulmonary tuberculosis when used concurrently with appropriate antituberculous chemotherapy
13. Loeffler’s syndrome
14. Aspiration pneumonitis
15. Hematologic Disorders (Acquired, autoimmune hemolytic anemia, Idiopathic thrombocytopenic purpura in adults, Secondary thrombocytopenia, Erythroblastopenia)
16. Neoplastic Diseases (Leukemias and lymphomas in adults, Acute leukemia of childhood)
17. Edematous States
18. Acute exacerbations of multiple sclerosis